Sign in
4

Changes in Ownership

Elanco Animal Health Inc Filed Acc 0001415889-25-017549

Options or other derivatives

  • PRESIDENT, CEO AND DIRECTOR acquired 200.52 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Simmons Jeffrey N · PRESIDENT, CEO AND DIRECTOR

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-06-13 Grant or award : show line 1 in the form Deferred Stock Units +200.52 $13.81 $2,769 16,655.66 D
Loading xslF345X05/form4-06172025_080623.xml…